glp 1 agonist muscle loss Balancing weight and in GLP1 receptor therapy Weighing the risk of GLP-1

Check out this video for some tips on how to make the most of this compound to achieve your weight loss goals

Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P

In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide

Lung transcriptome of e-cigarette users reveals changes related to chronic lung disease

As generic and compounded versions of GLP-1 medications become more available and brand-name prices potentially decrease, insurance companies will face less financial incentive to maintain restrictive BMI thresholds